Industry commitment to the science of safety

by Viraj Suvarna
Published 2011-01-01

Phase IV of Drug Development

by Viraj Suvarna
Published 2010-01-01

′Consort 2010: A standard for reporting clinical trials revised anew?

by Viraj Suvarna
Published 2010-01-01

Comparisons are odious

by Viraj Suvarna
Published 2014-01-01

Investigator initiated trials (IITs)

by Viraj Suvarna
Published 2012-01-01

Commentary on STOP DIABETES study

by Viraj Suvarna, Jignesh Ved
Published 2019-01-01

Pharmacovigilance Symposium ISCR Annual Conference Jan 5, 2013: Safety aspects of hard endpoint or outcome trials

by Viraj Suvarna, Indu Nambiar, Shoibal Mukherjee, Mohandas K Mallath
Published 2013-01-01

Long-term efficacy and safety of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes in Indian subgroup: Results from a 76-week extension trial of phase iii, doub...

by Sunil Gupta, Shehla Shaikh, Pooja Joshi, Shraddha Bhure, Viraj Suvarna
Published 2017-01-01

Health technology assessment and its role in the future development of the Indian healthcare sector

by Bastian Hass, Jayne Pooley, Martin Feuring, Viraj Suvarna, Adrian E Harrington
Published 2012-01-01

Practical challenges in conducting respiratory studies

by Sanjay D Hake, Mahesh L Patil, Tapankumar M Shah, Partha M Gokhale, Viraj Suvarna
Published 2015-01-01

Involvement of general public in biomedical research

by C S Pramesh, R Venkataramanan, Viraj Suvarna, Nishu Singh Goel, S Lakshman, Viji Venkatesh, Vandana Gupta, Rajendra Badwe
Published 2016-01-01